FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)

View source ↗

Summary

FDA approved a supplemental application for AIMOVIG (erenumab) submitted by Amgen, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• AIMOVIG (ERENUMAB-AOOE)

Snippet

SUPPL AP for AIMOVIG (ERENUMAB-AOOE)